TMB is a human bone-derived technology, without an additional carrier, indicated for homologous use. It can be added to any allograft and/or be mixed with saline, blood or BMA, enhancing the osteoinductive potential and the handling characteristics.
TMB offers immediate access to natural growth factors found in human bone and helps assist allograft placement/shape during surgical placement.
Surgeons report excellent handling characteristics and reduced processing time compared to leading alternatives such as Infuse® and Augment®. Available in multiple sizes.
TMB™ is a platform technology
TMB can boost any allograft, creating a range of ready-to-use products with superior characteristics.
On-going product development is focused on specific applications where pre-clinical studies demonstrated increased efficacy and efficiency at par with autograft performance.
TMB addresses an unmet need
Current standard of care
Today’s products are not well fitted to treat all patients with compromised bone healing
TMB adds to the standard of care
TMB is designed for all patients with compromised bone healing
Recombinant solutions are used off-label for a variety of indications
TMB addresses each clinical use as a bone graft substitute product
Current DBM products do not have instant access to natural human growth factors
Autograft may not be an option in patients with compromised bone healing
TMB gives instant access to natural human growth factors
TMB can enhance any existing allograft available today
TMB addresses an unmet need
Current standard of care
Today’s products are not well fitted to treat all patients with compromised bone healing
Recombinant solutions are used off-label for a variety of indications
Current DBM products do not have instant access to natural human growth factors
Autograft may not be an option in patients with compromised bone healing
TMB adds to the standard of care
TMB is designed for all patients with compromised bone healing
TMB addresses each clinical use as a bone graft substitute product
TMB gives instant access to natural human growth factors
TMB can enhance any existing allograft available today
TMB current US market status
Additional Product Information
AATB accredited manufacturing cleanroom ISO Certified facility located in Irvine, California, USA
Fully qualified and validated process
US/EU Patent pending technology
Low terminal sterilization dose with a sterility assurance level (SAL) of 10-6 and 3-year shelf life
Application
Clinical evaluation by experienced clinicians in the foot & ankle and spinal fusion procedures.
Exceptional handling characteristics leading to ease of use
Clinicals results at 6 months indicate TMB is a safe and effective bone graft for multiple foot and ankle surgical procedures
TMB shows high osteoinductive potential compared to alternative technologies
Removing reliance on recombinant solutions
TMB gives instant access to more natural BMPs than current alternatives